Effect of Vitamin D on Blood Glucose Control

Phase 3

Conditions: Condition 1: Diabetes. Condition 2: Vitamin D deficiency.
Type 2 diabetes mellitus
Vitamin D deficiency
E11.00

Registration Number: IRCT20190505043480N1

Lead Sponsor: Kashan University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: All

Target Recruitment: 80

Inclusion Criteria

It's been over 2 years since the diagnosis of type 2 diabetes
Detection of Type 2 diabetes according to standard criteria
HbA1C criteria range from 8-7
Fasting Blood glucose under 200
Using of oral Glucose-lowering Agents
Not taking vitamin D and calcium supplements at least 3 months ago, not taking medications that affect vitamin D metabolism (corticosteroids, calcitonin, cytotoxic drugs and immunosuppressive drugs, anticonvulsants) at least 3 months ago, lack of diseases that affect the metabolism of vitamins D effects (such as liver, endocrine, and cancer)
Desire to cooperate in designing and completing a written questionnaire
he level of vitamin D is between 10 and 19.9
Age between 30-85

Exclusion Criteria

Malnutrition, Infertility, Oligomenorrhea, Pregnancy, Breastfeeding, Malignancy
Smoking, alcohol consumption
Immobilization for more than a week
Acute and chronic active infections, acute and chronic inflammatory diseases, cardiovascular, liver, kidney, thyroid and parathyroid disorders

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Glycosylated hemoglobin(HbA1c). Timepoint: Before starting the study and 12 weeks after starting vitamin D. Method of measurement: Laboratory.;Vitamin D levels. Timepoint: Before starting the study and 12 weeks after starting vitamin D. Method of measurement: Laboratory.

Secondary Outcome Measures

Name	Time	Method
Changes in level of liver enzymes(AST-ALT-ALK). Timepoint: Before the study began and 12 weeks later. Method of measurement: laboratory.;Changes in lipid profiles (LDL-HDL-TG). Timepoint: Before the study began and 12 weeks later. Method of measurement: laboratory.;Renal Profile Changes (BUN-Creatinine). Timepoint: Before the study began and 12 weeks later. Method of measurement: laboratory.